Johnson & Johnson (JNJ) Tops Q4 EPS by 2c; Guides FY13 EPS Below Views
Tweet
Share
E-mailGet Alerts JNJ Hot Sheet
Price: $260.35 -0.66%
Financial Fact:
Selling, marketing and administrative expenses: 4.77B
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Selling, marketing and administrative expenses: 4.77B
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Johnson & Johnson (NYSE: JNJ) reported Q4 EPS of $1.19, $0.02 better than the analyst estimate of $1.17. Revenue for the quarter came in at $17.6 billion versus the consensus estimate of $17.67 billion.
Johnson & Johnson sees FY2013 EPS of $5.35-.5.45, versus the consensus of $5.49.
For earnings history and earnings-related data on Johnson & Johnson (JNJ) click here.
Johnson & Johnson sees FY2013 EPS of $5.35-.5.45, versus the consensus of $5.49.
For earnings history and earnings-related data on Johnson & Johnson (JNJ) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
- Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
